Patrick Pilie

Patrick Pilie

M D Anderson Cancer Center University of Texas - Houston / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1406921
MD Anderson Cancer Center
person_outline Patrick Pilie's MOST POPULAR ARTICLES
1-) State-of-the-art strategies for targeting the DNA damage response in cancerPG Pilié, C Tang, GB Mills, TA YapNature reviews Clinical oncology 16 (2), 81-104, 20196082019
2-) High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer typesDJ McGrail, PG Pilié, NU Rashid, L Voorwerk, M Slagter, M Kok, ...Annals of oncology 32 (5), 661-672, 20213382021
3-) PARP Inhibitors: Extending Benefit Beyond BRCA-Mutant CancersPARP Inhibitors: Benefit Beyond BRCAPG Pilié, CM Gay, LA Byers, MJ O\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Connor, TA YapClinical Cancer Research 25 (13), 3759-3771, 20192232019
4-) Development of PARP and immune-checkpoint inhibitor combinationsRA Stewart, PG Pilié, TA YapCancer research 78 (24), 6717-6725, 20182002018
5-) Niraparib and abiraterone acetate for metastatic castration-resistant prostate cancerKN Chi, D Rathkopf, MR Smith, E Efstathiou, G Attard, D Olmos, JY Lee, ...Journal of Clinical Oncology 41 (18), 3339-3351, 20231822023